Neimeth International Pharmaceuticals Plc is preparing a major financial restructuring, asking shareholders to approve a N1.98 billion capital reorganisation on March 31, 2026.
While the term sounds technical, Neimeth aims to clear past losses on its books so it can resume paying dividends to shareholders.
Following an order from the Federal High Court, the company will hold a virtual meeting to seek final approval from investors.
To understand the move, it helps to look at how a company’s shareholders’ equity is structured.
The Share Premium Account: This is extra money investors paid for shares in the past. Neimeth currently has N2.38 billion here. By law, this amount is locked and cannot be distributed as dividends.
The Revenue Reserve: This is where the company records its accumulated profits and losses. Due to past challenges, Neimeth has an accumulated loss of about N1.88 billion in this account.
Neimeth plans to transfer N1.99 billion from the share premium account into the revenue reserve. This will effectively offset the accumulated losses.
The timing shows an improving financial standing. After a difficult 2024, when the company recorded a loss of over N885 million, Neimeth returned to profitability. In the 2025 financial year, it reported a full-year profit of N982.1 million.
However, under the company law (CAMA), a firm cannot pay dividends if it still carries accumulated losses, even if it has returned to profit. This restructuring is intended to remove that restriction and pave the way for future dividend payments.
What this Means for the Everyday Investor
If you own Neimeth shares, here is the bottom line:
No New Shares: Your number of shares and ownership stake will not change.
No Immediate Cash: This is not a payout but an accounting adjustment.
Future Dividends: This benefit is that it clears legal limitations that have prevented the company from paying dividends.
Stronger Balance Sheet: A cleaner balance sheet may improve the company’s standing with lenders and institutional investors over time.
How to Vote
The proposal requires strong backing, with at least 75% of voting shareholders must approve it for the plan to pass.
The virtual meeting will be held on March 31. Shareholders on record as of March 23, 2026, are eligible to vote. Participation requires registration on the Meristem Registrars portal.
The Final Verdict
This restructuring amounts to financial reset. It does not generate new cash or guarantee higher profits in the short term, but it addresses a key structural issue.
Neimeth has already returned to profitability. This step ensures those profits can, in time, be distributed to shareholders.
